1-14 of 14
Jane Reese
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Clinical Trial of Fully Human Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Brenda W Cooper, Molly Megan Gallogly, Leland Metheny, Rebecca B. Klisovic, Kirsten Marie Boughan, Jane Reese Koc, Darong Wu, Changchun Deng, Koen Van Besien, Rose Tupta, Dina Schneider, Lisa Ciarrone, Marcos de Lima, Paolo F. Caimi, Benjamin K. Tomlinson
Journal: Blood
Blood (2023) 142 (Supplement 1): 6872.
https://doi.org/10.1182/blood-2023-191153
Published: 2023
Journal Articles

Circulating Tumor DNA Correlation with Lymphoma Response and Survival Outcomes at Multiple Time Points of Anti - CD19 CAR T Cell Therapy

Paolo F Caimi, Martina Di Trani, Armin Ghobadi, Jane Reese, Benjamin Tomlinson, Folashade Otegbeye, Kirsten M Boughan, Molly Gallogly, Leland Metheny, Brenda W. Cooper, Boro Dropulic, Marcos J.G. de Lima, Carmelo Carlo-Stella
Journal: Blood
Blood (2022) 140 (Supplement 1): 7457–7459.
https://doi.org/10.1182/blood-2022-170629
Published: 2022
Journal Articles

Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)

David J. Chung, Nina Shah, Dina Stroopinsky, Juan WU, Lina Bisharat, Natalie S. Callander, Brent R. Logan, Kenneth C. Anderson, Thinle Chodon, Meera Mohan, Steven Devine, Yvonne A. Efebera, Nancy Geller, Peiman Hematti, Leona A. Holmberg, Alan Howard, Bryon Johnson, Hillard M Lazarus, Ehsan Malek, Philip L. McCarthy, David H. McKenna, Adam M. Mendizabal, Nikhil C. Munshi, Lynn O'Donnell, Aaron P. Rapoport, Ajay K. Nooka, Jane Reese, Robert J. Soiffer, Lynne Uhl, Giulia Cheloni, Dimitra Karagkouni, Ioannis Vlachos, James W. Young, Jacalyn Rosenblatt, Edmund K. Waller, Marcelo C Pasquini, David Avigan
Journal: Blood
Blood (2021) 138 (Supplement 1): 899.
https://doi.org/10.1182/blood-2021-149659
Published: 2021
Journal Articles

Sequential Single Cell Transcriptional and Protein Marker Profiling Reveals Tigit As a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin's Lymphoma

Zachary Jackson, Changjin Hong, Robert Schauner, Boro Dropulic, Paolo F. Caimi, Marcos J.G. de Lima, Kalpana Gupta, Jane Reese, Tae Hyun Hwang, David Wald
Journal: Blood
Blood (2021) 138 (Supplement 1): 164.
https://doi.org/10.1182/blood-2021-152813
Published: 2021
Journal Articles

Final Results of a Phase 1 Study of AntiCD19 CAR-T Cells with TNFRSF19 Transmembrane Domain

Paolo F. Caimi, Armin Ghobadi, Jane Reese, Benjamin Tomlinson, Folashade Otegbeye, Julie K Ritchey, Tabatha Trummer, Jennifer Schiavone, Kayla Zamborsky, Linda G Eissenberg, Julia Hollaway, Dina Schneider, Kristen Bakalarz, Kirsten M Boughan, Leland Metheny, III, Seema Patel, Erin Galloway, Molly Gallogly, Winfried Krueger, Michael Kadan, Gabriela Pacheco Sanchez, Ashish Sharma, David Wald, Brenda W. Cooper, John F. DiPersio, Rafick Sekaly, Rimas J Orentas, Boro Dropulic, Marcos J.G. de Lima
Journal: Blood
Blood (2021) 138 (Supplement 1): 3833.
https://doi.org/10.1182/blood-2021-151155
Published: 2021
Journal Articles

Whole-Exome Sequencing Identifies a Somatic Cell Mutation Signature That Predicts Relapse Risk and Survival Probability in Multiple Myeloma

Ehsan Malek, MD, E. Ricky Chan, PhD, Daniel Qu, Jane Reese, Robert Fox, Byung-Gyu Kim, PhD DVM, Paolo F Caimi, MD, Marcos de Lima, MD, James J. Driscoll, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-142791
Published: 2020
Journal Articles

CAR-T Therapy for Lymphoma with Prophylactic Tocilizumab: Decreased Rates of Severe Cytokine Release Syndrome without Excessive Neurologic Toxicity

Paolo F Caimi, MD, Ashish Sharma, Patricio Rojas, MD, Seema Patel, PharmD, Jane Reese, Folashade Otegbeye, MBBChir,MPH, Andrew Worden, Michael Kadan, Michael Maschan, MD PhD, Rimas J Orentas, PhD, Boro Dropulic, PhDMBA, Rafick Sekaly, Marcos de Lima, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-143114
Published: 2020
Journal Articles

Impact of Daratumumab on Stem Cell Collection, Graft Composition and Engraftment Among Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant

Shivaprasad Manjappa, MDMBBS, Robert Fox, Jane Reese, Amin Firoozamand, MD, Hannah Schmikla, RN, Savannah Nall, RN, Merle Kolk, Paolo F Caimi, MD, James J. Driscoll, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–37.
https://doi.org/10.1182/blood-2020-142115
Published: 2020
Journal Articles

Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory Lymphomas

Paolo F Caimi, MD, Jane Reese, Folashade Otegbeye, MBBChir,MPH, Dina Schneider, PhD, Kristen Bakalarz, CNP, Kirsten M Boughan, DO, Brenda Cooper, MD, Molly M Gallogly, MD PhD, Erin Galloway, RN BSN, Winfried Kruger, Andrew Worden, Michael Kadan, Filipa Blasco Lopes, Ashish Sharma, Ehsan Malek, MD, Leland Metheny, III, MD, Seema Patel, PharmD, Benjamin K. Tomlinson, MD, David Wald, MD PhD, Rafick-Pierre Sekaly, Rimas Orentas, PhD, Boro Dropulic, PhD, Marcos de Lima, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4074.
https://doi.org/10.1182/blood-2019-131300
Published: 2019
Journal Articles

Automated Generation and Phenotypic Characterization of Clinical Grade CD19 CAR-T Cells

Ashish Sharma, Anne Roe, Filipa Blasco Lopes, Ruifu Liu, Jane Reese, Susan Pereira Ribeiro, Rafick-Pierre Sekaly, PhD, Marcos de Lima, MD, David Wald, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1675.
https://doi.org/10.1182/blood-2018-99-120098
Published: 2018
Journal Articles

Treatment of Secondary Post-Transplant Engraftment Failure with Donor CD34+ Enriched, T-Cell Depleted Peripheral Blood Stem Cells Isolated By the Clinimacs® System

Paolo Caimi, MD, Jane Reese, Merle Kolk, Robert Fox, Kari Eckmeyer, RN, Erin Galloway, RN BSN, Gina Hoffman, Ehsan Malek, MD, Leland Metheny, MD, Ben K. Tomlinson, MD, Richard Creger, PhD, Brenda W. Cooper, MD, Hillard M Lazarus, MD, Marcos de Lima, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1956.
https://doi.org/10.1182/blood.V130.Suppl_1.1956.1956
Published: 2017
Journal Articles

Viral Insertion Safety in Patients with Glioblastoma Who Received a Novel Lentiviral MGMT-P140K Gene Therapy to Protect Bone Marrow from Chemotherapy: No Dominant Clonal Evolution Observed with Chemo-Selection

Hua Fung, Andrew E Sloan, Jane Reese, Basem M. William, MD, Karen Lingas, Lisa R Rogers, Heather Embree, Hillard M. Lazarus, Donna Kane, Boro Dropulic, Stanton L. Gerson
Journal: Blood
Blood (2014) 124 (21): 4801.
https://doi.org/10.1182/blood.V124.21.4801.4801
Published: 2014
Journal Articles

Fingolimod Expands Human Umbilical Cord Blood Cells (UCB) in Vitro and Improves Engraftment Rate of Human UCB in Sublethally Irradiated NOD SCID Gamma (NSG) Mice

Basem M. William, MD, Stephen Moreton, Jane Reese, Pingfu Fu, Ph., D., Julia V. Busik, PhD, Marcos de Lima, MD, David N. Wald, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2413.
https://doi.org/10.1182/blood.V124.21.2413.2413
Published: 2014
Journal Articles

Regulatory-Approval Driven Safety and Efficacy of MGMTP140K Lentivirus Transduction of Human CD34+ Cells for a Phase I Clinical Trial for Upfront Treatment of Glioma,

Yulan Qing, PhD, Jane Reese, Min Liu, Amar Desai, Heather Embree, Boro Dropulic, MBA, PhD, Stanton L. Gerson, MD
Journal: Blood
Blood (2011) 118 (21): 4177.
https://doi.org/10.1182/blood.V118.21.4177.4177
Published: 2011